Latest Breaking News On - Botox injections - Page 19 : comparemela.com

Press release content from Business Wire. The AP news staff was not involved in its creation. Revance Provides Corporate Update and Anticipated Milestones for 2021 January 7, 2021 GMT NASHVILLE, Tenn. (BUSINESS WIRE) Jan 7, 2021 Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today provided a corporate update, product pipeline timing and anticipated milestones for 2021. Financial Update and Key Launch Metrics: Preliminary Unaudited Full Year 2020 RHA® Collection Revenue of Between $12.5 Million and $13.0 Million. The company expects its first full quarter of unaudited RHA® Collection revenue to be between $9.5 million and $10.0 million for the fourth quarter 2020, bringing full year RHA® Collection revenue to be between $12.5 million and $13.0 million. The company launched the RHA® Collection in September 2020.

United statesLaurence wattsJessica serraSara fahyNadine toskMark foleyAllergan incDrug administrationInjection in muscle movement disordersExchange commissionGilmartin groupHintmd developmentRevance therapeutics incSecurities exchangeTennessee department of economicCommunity development